Zyprexa, Abilify, Risperdal e Seroquel collegati a Rapido Aumento di Peso nei Bambini

Zyprexa, Abilify, Risperdal, and Seroquel Linked to Rapid Weight Gain in Children

October 29, 2009

Washington, DCThe largest study of its kind to show an association between atypical antipsychotics such as Zyprexa, and rapid weight gain and metabolic changes that can lead to diabetes and hypertension was published Wednesday in the Journal of the American Medical Association (JAMA). The study was conducted in 272 children aged between 4 and 19 years. 

Study investigators evaluated the four top selling antipsychotic medications used in the treatment of schizophrenia and bipolar disorder, namely Zyprexa (Eli Lilly & Co); Abilify, (Bristol-Myers Squibb Co and Otsuka Pharmaceutical Co); Risperdal (Johnson & Johnson); and Seroquel ( AstraZeneca PLC).
Of the four atypical antipsychotics, Zyprexa caused the most weight gain over the course of the study – at nearly 19 lbs, a 15 percent increase. Importantly, Zyprexa was also found to significantly raise cholesterol, insulin, triglycerides and blood sugar levels, all of which can lead to the development of diabetes and heart disease.
Children taking Abilify, Risperdal, and Seroquel gained an average of between 10 and 13 pounds over the 11 weeks, and the drugs' impact on metabolic disease indicators varied.
In an article published in the Wall Street Journal (wsj.com), Christoph Correll, the study's lead author and a psychiatrist and scientist at the Feinstein Institute for Medical Research in Manhasset, NY, said, "The weight gain is much larger than we thought. It's massive, and it's the medication that caused it."

 

Legal Help Now - Aiuto Legale Adesso

 

#Zyprexa #Abilify #Risperdal #Seroquel #Obesità #Bambini 

#Diabete #Ipetensione #JAMA #WSJ

FDA Aggiornamento, Farmaci Antipsicotici in Gravidanza

FDA Updates Pregnancy Section Labeling for Antipsychotic Drugs

Washington, DC: The FDA has notified healthcare professionals that the pregnancy section of drug labels for the entire class of antipsychotic drugs has been updated. The new drug labels now contain more and consistent information about the potential risk for abnormal muscle movements (extrapyramidal signs or EPS) and withdrawal symptoms in newborns whose mothers were treated with these drugs during the third trimester of pregnancy.
Antipsychotic drugs included in this labeling change are Haldol, FazaClo, Fanapt, Clozaril, Risperdal, Zyprexa, Seroquel, Abilify, Geodon, Invega, Loxitane, Moban, Navane, Orap, Saphris, Stelazine, Thorazine, Symbyax.
The symptoms of EPS and withdrawal in newborns may include agitation, abnormally increased or decreased muscle tone, tremor, sleepiness, severe difficulty breathing, and difficulty in feeding. In some newborns, the symptoms subside within hours or days and do not require specific treatment; other newborns may require longer hospital stays.
Antipsychotic drugs are used to treat symptoms of psychiatric disorders such as schizophrenia and bipolar disorder.

Legal Help

If your child has suffered illness, an adverse health event or birth defect resulting from the use of any of the above products, please click the link below and your complaint will be sent to a lawyer who may evaluate your claim at no cost or obligation.

Last updated on Feb-22-2011

#FDA #Zyprexa #Seroquel #Gravidanza

Studio: farmaci come Abilify potrebbero non aiutare con lo stress

Study: Drugs Like Abilify May Not Help with Stress

August 27, 2011

Washington, DC
A new study suggests that drugs like Abilify may not be effective in dealing with severe stress. Furthermore because of the risk of Abilify side effects, these drugs may be more risky for patients than necessary. Concerns about Abilify side effects include problems with Abilify for children and concern about problems with Abilify and pregnancy.
The study, which was reported in The New York Times (08/02/11), suggests that drugs used to treat severe post-traumatic stress symptoms have approximately the same effectiveness as placebos but also carry serious side effects. Published in The Journal of the American Medical Association, the study examined the use of Risperdal to treat veterans with post-traumatic stress symptoms. Risperdal, an antipsychotic medication, is in the same class of drugs as Abilify and Seroquel, leading experts to conclude that the same results could be found of Abilify.

Researchers found that veterans who were given Risperdal to treat post-traumatic stress had a similar recovery rate as those who were given a placebo. After six months of treatment, approximately five percent of veterans in both groups recovered and between 10 and 20 percent had some improvement, but had not fully recovered. This led researchers to conclude that treatment with the medication did not have an overall benefit for the veterans.
In February 2011, the US Food and Drug Administration (FDA) issued a warning about the use of Abilify during pregnancy. According to the warning, use of Abilify while pregnant could cause abnormal muscle movements and withdrawal in infants exposed to the medications prior to birth. Symptoms of these conditions include agitation, abnormal muscle tone, tremors and severe difficulty breathing.
The FDA noted that a search of the Adverse Event Reporting System (AERS) through October 29, 2008, found 69 cases of neonatal events, including abnormal muscle movements or withdrawal with all antipsychotic drugs. The agency reported that it was not known if the cause of the events were drug toxicity or drug withdrawal. Onset of symptoms ranged from birth to one month after birth. According to the FDA, some infants recovered on their own, while others required intensive care and prolonged hospitalization.

Women who take Abilify and are pregnant or planning on becoming pregnant should discuss their options with their doctor.
Abilify Legal Help
#Abilify #Aripiprazole #Gravidanza #Veterani #Rischi

Abilify ed effetti collaterali

Abilify Side Effects
Last updated on Aug-19-2011

Abilify (known generically as aripiprazole) is in a class of drugs called atypical antipsychotics and is used to treat schizophrenia. Abilify side effects reportedly include an increased risk of diabetes and other blood sugar disorders, including hyperglycemia. Other aripiprazole side effects could include tremors and uncontrollable movements. 

Abilify Aripiprazole
darvondarvocetpillstackart Abilify is an atypical antipsychotic that is used to treat schizophrenia, bipolar disorder, major depressive disorder and irritability associated with autistic disorder. Antipsychotic medications have reportedly been linked to serious side effects including an increased risk of diabetes and other blood sugar disorders. They are also linked to a risk of harm to newborns. 

Abilify and Pregnancy

The US Food and Drug Administration issued a warning in February 2011 alerting patients to a risk of harm to a newborn when women who are pregnant or planning on becoming take medications such as Abilify. According to the warning, the medications could cause abnormal muscle movements and withdrawal symptoms when the infants were exposed to the medications during the third trimester. 

Aripiprazole Side Effects
According to the medication guide, elderly patients with dementia-related psychosis may be at an increased risk of death when taking Abilify. In 2008, the FDA requested that antipsychotic drugs, including Abilify, update their warnings to include the increased risk of death when Abilify is used to treat dementia in older patients. Furthermore, young patients with depression who take Abilify may be at an increased risk of suicidal thoughts or actions. 

Patients who take atypical antipsychotic medications may also be at an increased risk of developing hyperglycemia or diabetes. A 2009 study published in Psychopharmacology Bulletin found that patients taking an atypical antipsychotic medication were at a higher risk for developing diabetes. Researchers recommended that patients taking an antipsychotic medication be monitored for diabetes. 

Abilify and Veterans
A study published in The Journal of the American Medical Association suggests that antipsychotic medications such as Abilify may be no more effective than placebos at treating severe post-traumatic stress symptoms and may come with serious side effects. According to an article in The New York Times (08/02/11), the study focused on Risperdal but the results could extend to other drugs in the same class, including Seroquel and Abilify. 
Researchers found that patients who were given Risperdal to treat post-traumatic stress had the same rate of recovery—approximately five percent—as those treated with a placebo. Between 10 and 20 percent of patients in both groups reported some improvement. The concern is that patients might not receive any benefit from taking the antipsychotic medications but are still being put at risk of serious side effects. 

Abilify patients in California and across the US do not necessarily have to have suffered Abilify side effects to speak to a lawyer. If you used Abilify and it did not work for you, speak to a lawyer about your legal options. 
#Abilify #Aripiprazole #Gravidanza #EffettiCollaterali #Veterani

Abilify e comportamento compulsivo, ipersessualità, gioco d'azzardo, shopping compulsivo

Rolling the Dice with Abilify

February 6, 2016

Hackensack, NJ
Most consumers conversant with adverse reaction reports associated with pharmaceutical drugs are nonetheless surprised upon learning of a particular aspect of Abilify side effects that allegedly can leave an Abilify patient in financial ruin.
The problem with Abilify (aripiprazole) and similar drugs that impact dopamine in the brain is the potential for compulsive behavior - and specifically, gambling. To this end, a New Jersey man recently filed an Abilify lawsuit alleging that his use of the antidepressant left him with a $75,000 gambling debt.
According to court documents, plaintiff Jonathan Yun notes that his compulsive gambling emerged not long after he was prescribed Abilify in December 2010. During his compulsive gambling, Yun burned through about $75,000 before he stopped taking aripiprazole.
Once he stopped taking Abilify, in August 2013, the Abilify side effects related to his compulsive gambling simply vanished, or so it is alleged.
Yun asserts in his Abilify lawsuit that there was no indication on the Abilify label in the United States that suggested adverse reactions with regard to compulsive behavior. “The labeling for Abilify in the United States contains no mention that pathological gambling has been reported in patients prescribed Abilify,” the lawsuit states.
And yet, Yun asserts that the US Food and Drug Administration (FDA) received various reports suggesting aripiprazole side effects over an eight-year period ending in 2013. “An FDA report showed that Abilify accounted for at least fifty-four reports of compulsive or impulsive behavior problems, including thirty reports of compulsive gambling, twelve reports of impulsive behavior, nine reports of hypersexuality, and three reports of compulsive shopping.

“An analysis of the FDA Adverse Event Reporting System shows an escalating number of reports” suggesting compulsive gambling: “Twenty-nine reports of gambling behavior were made to the FDA in 2014” about Abilify, according to the complaint.

And yet, Yun alleges there remained no useful warning on US product labels. In contrast, the European Medicines Agency required proper warnings, beginning in 2012, against the risk for what it deemed pathological gambling. More recently, this past November (2015), “Canadian regulators concluded that there is ‘a link between the use of aripiprazole [Abilify] and a possible risk of pathological gambling or hypersexuality,’ and found an increased risk of pathological (uncontrollable) gambling and hypersexuality with the use of Abilify.”

In his Abilify litigation, Yun asserts that defendants Bristol-Myers Squibb and Otsuka Pharmaceutical Co. Ltd. “had, or should have had knowledge that Abilify can cause compulsive behaviors like gambling,” and that “despite their significant collective resources, and signals that Abilify is associated with compulsive behaviors such as gambling, [they] have failed to fully and adequately test or research Abilify and its association with compulsive behaviors.”

Yun filed his Abilify lawsuit January 12 in Bergen County Court.

Abilify Legal Help

#Abilify #Aripiprazole #FDA #ipersessualità #ComportamentoCompulsivo

Zyprexa, Abilify, Risperdal, Seroquel, Causano Rapido Aumento di Peso nei Bambini

#Zyprexa #Abilify #Risperdal #Seroquel #AumentoDiPeso #Obesità #Bambini #Antipsicotici #Schizofrenia
#DisturboBipolare #JAMA #AMA #Drugs #Colesterolo #Insulina #Trigliceridi #Diabete